Cargando…

Germline BAP1 mutations predispose to malignant mesothelioma

Because only a small fraction of asbestos-exposed individuals develop malignant mesothelioma(1), and because mesothelioma clustering is observed in some families(1), we searched for genetic predisposing factors. We discovered germline mutations in BAP1 (BRCA1-associated protein 1) in two families wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testa, Joseph R., Cheung, Mitchell, Pei, Jianming, Below, Jennifer E., Tan, Yinfei, Sementino, Eleonora, Cox, Nancy J., Dogan, A. Umran, Pass, Harvey I., Trusa, Sandra, Hesdorffer, Mary, Nasu, Masaki, Powers, Amy, Rivera, Zeyana, Comertpay, Sabahattin, Tanji, Mika, Gaudino, Giovanni, Yang, Haining, Carbone, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184199/ https://www.ncbi.nlm.nih.gov/pubmed/21874000 http://dx.doi.org/10.1038/ng.912

Ejemplares similares

Evaluation of clonal origin of malignant mesothelioma
por: Comertpay, Sabahattin, et al.
Publicado: (2014)

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response
por: Osmanbeyoglu, Hatice Ulku, et al.
Publicado: (2022)

Germline BAP1 mutations induce a Warburg effect
por: Bononi, Angela, et al.
Publicado: (2017)

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s
por: Carbone, Michele, et al.
Publicado: (2015)

Germline mutations in BAP1 predispose to melanocytic tumors
por: Wiesner, Thomas, et al.
Publicado: (2011)

Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
por: Carbone, Michele, et al.
Publicado: (2023)

Investigating palygorskite’s role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity
por: Larson, David, et al.
Publicado: (2016)

Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma
por: Bononi, Angela, et al.
Publicado: (2020)

Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
por: Zolondick, Alicia A., et al.
Publicado: (2021)

BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation
por: Bononi, Angela, et al.
Publicado: (2017)

HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis
por: Gaudino, Giovanni, et al.
Publicado: (2014)

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
por: Pellegrini, Laura, et al.
Publicado: (2017)

BAP1 is a novel regulator of HIF-1α
por: Bononi, Angela, et al.
Publicado: (2023)

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017)

Data supporting the roles of BAP1, STING, and IFN-β in ISGF3 activation in ccRCC
por: Langbein, Lauren E., et al.
Publicado: (2022)

Consensus Report of the 2015 Weinman International Conference on Mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016)

Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With BAP1 Germline Mutation: A Case Report
por: MacLean, Alyssa, et al.
Publicado: (2022)

How asbestos and other fibers cause mesothelioma
por: Gaudino, Giovanni, et al.
Publicado: (2020)

Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma
por: Kalra, Neetu, et al.
Publicado: (2015)

Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
por: Yang, H, et al.
Publicado: (2015)

Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members
por: Kittaneh, Muaiad, et al.
Publicado: (2018)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
por: Ladanyi, Marc, et al.
Publicado: (2019)

In vitro evaluation of the effects of capsaicin on normal and cancerous cells of human cartilage
por: HELVACI, Nagihan, et al.
Publicado: (2018)

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
por: Szymiczek, Agata, et al.
Publicado: (2017)

Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Daou, Salima, et al.
Publicado: (2018)

Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis
por: Tan, Yinfei, et al.
Publicado: (2020)

Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene
por: Ghafoor, Azam, et al.
Publicado: (2021)

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
por: Alakus, Hakan, et al.
Publicado: (2015)

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
por: Guazzelli, Alice, et al.
Publicado: (2019)

The Rarest of the Rare: A Case of BAP1-Mutated Primary Peritoneal Mesothelioma
por: Gupta, Aanchal, et al.
Publicado: (2021)

Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma
por: Pandey, Gaurav Kumar, et al.
Publicado: (2023)

BAP1 hereditary cancer predisposition syndrome: a case report and review of literature
por: Klebe, Sonja, et al.
Publicado: (2015)

BAP1: role in carcinogenesis and clinical implications
por: Kobrinski, Daniel A., et al.
Publicado: (2020)

A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
por: Aoude, Lauren G., et al.
Publicado: (2013)

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
por: Shrestha, Raunak, et al.
Publicado: (2019)

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma
por: Ishii, Yuki, et al.
Publicado: (2021)

Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health
por: Vimercati, Luigi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pbsh809vbmadfjl0omov09f8n6